TLR7 agonist 30
TLR7 agonist 30 (compound 2) is a cleavable linker-drug conjugate for ADC development, derived from TLR7 agonist 1. It demonstrates robust anti-tumor efficacy in research models, applicable for studying immune-stimulating antibody conjugates in both in vitro and in vivo oncology research.
Product Specifications
Field of Research
Immunology & Inflammation, Pharmacology & Drug Discovery; Cell Biology
Molecular Formula
C72H116N14O22
Molecular Weight
1529.77
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
